Europe Alzheimers Drug Market Research Report Forecast 2017-2021

March 2017 | 129 pages | ID: EE5A2AE3054EN
S&P Consulting

Abstracts

The Europe Alzheimers Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Alzheimers Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Alzheimers Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Alzheimers Drug Market Analysis by Countries:

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

The Major players reported in the market include:
Eisai
Pfizer
Decartis
Shire
Janssen
Forest Laboratories
H. Lundbeck
Merz
Daiichi Sankyo
Europe Alzheimers Drug Market Analysis by Product:
Centrally acting AChE inhibintors
NMDA antagonists
Type 3
Europe Alzheimers Drug Market Analysis by Application:
Application 1
Application 2
Application 3

REASONS FOR BUYING THIS REPORT

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Europe Alzheimers Drug Sales Market Report Forecast 2017-2021

1 ALZHEIMERS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Alzheimers Drug
1.2 Classification of Alzheimers Drug
  1.2.1 Centrally acting AChE inhibintors
  1.2.2 NMDA antagonists
  1.2.3 Type
1.3 Application of Alzheimers Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Alzheimers Drug Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Alzheimers Drug (2012-2021)
  1.5.1 Europe Alzheimers Drug Sales and Growth Rate (2012-2021)
  1.5.2 Europe Alzheimers Drug Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON ALZHEIMERS DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ALZHEIMERS DRUG MANUFACTURING COST ANALYSIS

3.1 Alzheimers Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Alzheimers Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Alzheimers Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Alzheimers Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE ALZHEIMERS DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Alzheimers Drug Market Competition by Manufacturers
  5.1.1 Europe Alzheimers Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Alzheimers Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Alzheimers Drug (Volume and Value) by Type
  5.2.1 Europe Alzheimers Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Alzheimers Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe Alzheimers Drug (Volume and Value) by Countries
  5.3.1 Europe Alzheimers Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Alzheimers Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe Alzheimers Drug (Volume) by Application

6 GERMANY ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Alzheimers Drug Sales and Value (2012-2017)
  6.1.1 Germany Alzheimers Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany Alzheimers Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Alzheimers Drug Sales Price Trend (2012-2017)
6.2 Germany Alzheimers Drug Sales and Market Share by Manufacturers
6.3 Germany Alzheimers Drug Sales and Market Share by Type
6.4 Germany Alzheimers Drug Sales and Market Share by Application

7 FRANCE ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France Alzheimers Drug Sales and Value (2012-2017)
  7.1.1 France Alzheimers Drug Sales and Growth Rate (2012-2017)
  7.1.2 France Alzheimers Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France Alzheimers Drug Sales Price Trend (2012-2017)
7.2 France Alzheimers Drug Sales and Market Share by Manufacturers
7.3 France Alzheimers Drug Sales and Market Share by Type
7.4 France Alzheimers Drug Sales and Market Share by Application

8 UK ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Alzheimers Drug Sales and Value (2012-2017)
  8.1.1 UK Alzheimers Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK Alzheimers Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK Alzheimers Drug Sales Price Trend (2012-2017)
8.2 UK Alzheimers Drug Sales and Market Share by Manufacturers
8.3 UK Alzheimers Drug Sales and Market Share by Type
8.4 UK Alzheimers Drug Sales and Market Share by Application

9 RUSSIA ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Alzheimers Drug Sales and Value (2012-2017)
  9.1.1 Russia Alzheimers Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia Alzheimers Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Alzheimers Drug Sales Price Trend (2012-2017)
9.2 Russia Alzheimers Drug Sales and Market Share by Manufacturers
9.3 Russia Alzheimers Drug Sales and Market Share by Type
9.4 Russia Alzheimers Drug Sales and Market Share by Application

10 ITALY ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Alzheimers Drug Sales and Value (2012-2017)
  10.1.1 Italy Alzheimers Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy Alzheimers Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Alzheimers Drug Sales Price Trend (2012-2017)
10.2 Italy Alzheimers Drug Sales and Market Share by Manufacturers
10.3 Italy Alzheimers Drug Sales and Market Share by Type
10.4 Italy Alzheimers Drug Sales and Market Share by Application

11 SPAIN ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Alzheimers Drug Sales and Value (2012-2017)
  11.1.1 Spain Alzheimers Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain Alzheimers Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Alzheimers Drug Sales Price Trend (2012-2017)
11.2 Spain Alzheimers Drug Sales and Market Share by Manufacturers
11.3 Spain Alzheimers Drug Sales and Market Share by Type
11.4 Spain Alzheimers Drug Sales and Market Share by Application

12 BENELUX ALZHEIMERS DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Alzheimers Drug Sales and Value (2012-2017)
  12.1.1 Benelux Alzheimers Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Alzheimers Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Alzheimers Drug Sales Price Trend (2012-2017)
12.2 Benelux Alzheimers Drug Sales and Market Share by Manufacturers
12.3 Benelux Alzheimers Drug Sales and Market Share by Type
12.4 Benelux Alzheimers Drug Sales and Market Share by Application

13 EUROPE ALZHEIMERS DRUG MANUFACTURERS ANALYSIS

13.1 Eisai
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Pfizer
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Decartis
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Shire
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Janssen
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Forest Laboratories
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 H. Lundbeck
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Merz
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Daiichi Sankyo
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ALZHEIMERS DRUG MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Alzheimers Drug Market Forecast by Type (2017-2021)
15.9 Europe Alzheimers Drug Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alzheimers Drug
Table Classification of Alzheimers Drug
Figure Europe Sales Market Share of Alzheimers Drug by Type in 2015
Table Application of Alzheimers Drug
Figure Europe Sales Market Share of Alzheimers Drug by Application in 2015
Figure Germany Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure France Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure UK Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure Russia Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure Italy Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure Spain Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure Benelux Alzheimers Drug Revenue and Growth Rate (2012-2021)
Figure Europe Alzheimers Drug Sales and Growth Rate (2012-2021)
Figure Europe Alzheimers Drug Revenue and Growth Rate (2012-2021)
Table Europe Alzheimers Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Alzheimers Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Alzheimers Drug Sales Share by Manufacturers
Figure 2016 Alzheimers Drug Sales Share by Manufacturers
Table Europe Alzheimers Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Alzheimers Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Alzheimers Drug Revenue Share by Manufacturers
Table 2016 Europe Alzheimers Drug Revenue Share by Manufacturers
Table Europe Alzheimers Drug Sales and Market Share by Type (2012-2017)
Table Europe Alzheimers Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Alzheimers Drug by Type (2012-2017)
Figure Europe Alzheimers Drug Sales Growth Rate by Type (2012-2017)
Table Europe Alzheimers Drug Revenue and Market Share by Type (2012-2017)
Table Europe Alzheimers Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alzheimers Drug by Type (2012-2017)
Figure Europe Alzheimers Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Alzheimers Drug Sales and Market Share by Countries (2012-2017)
Table Europe Alzheimers Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Alzheimers Drug by Countries (2012-2017)
Table Europe Alzheimers Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Alzheimers Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Alzheimers Drug by Countries (2012-2017)
Table Europe Alzheimers Drug Sales and Market Share by Application (2012-2017)
Table Europe Alzheimers Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Alzheimers Drug by Application (2012-2017)
Figure Germany Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure Germany Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure Germany Alzheimers Drug Sales Price Trend (2012-2017)
Table Germany Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table Germany Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Alzheimers Drug Sales by Type (2015 and 2016)
Table Germany Alzheimers Drug Market Share by Type (2015 and 2016)
Table Germany Alzheimers Drug Sales by Application (2015 and 2016)
Table Germany Alzheimers Drug Market Share by Application (2015 and 2016)
Figure France Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure France Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure France Alzheimers Drug Sales Price Trend (2012-2017)
Table France Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table France Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table France Alzheimers Drug Sales by Type (2015 and 2016)
Table France Alzheimers Drug Market Share by Type (2015 and 2016)
Table France Alzheimers Drug Sales by Application (2015 and 2016)
Table France Alzheimers Drug Market Share by Application (2015 and 2016)
Figure UK Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure UK Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure UK Alzheimers Drug Sales Price Trend (2012-2017)
Table UK Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table UK Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table UK Alzheimers Drug Sales by Type (2015 and 2016)
Table UK Alzheimers Drug Market Share by Type (2015 and 2016)
Table UK Alzheimers Drug Sales by Application (2015 and 2016)
Table UK Alzheimers Drug Market Share by Application (2015 and 2016)
Figure Russia Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure Russia Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure Russia Alzheimers Drug Sales Price Trend (2012-2017)
Table Russia Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table Russia Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Alzheimers Drug Sales by Type (2015 and 2016)
Table Russia Alzheimers Drug Market Share by Type (2015 and 2016)
Table Russia Alzheimers Drug Sales by Application (2015 and 2016)
Table Russia Alzheimers Drug Market Share by Application (2015 and 2016)
Figure Italy Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure Italy Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure Italy Alzheimers Drug Sales Price Trend (2012-2017)
Table Italy Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table Italy Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Alzheimers Drug Sales by Type (2015 and 2016)
Table Italy Alzheimers Drug Market Share by Type (2015 and 2016)
Table Italy Alzheimers Drug Sales by Application (2015 and 2016)
Table Italy Alzheimers Drug Market Share by Application (2015 and 2016)
Figure Spain Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure Spain Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure Spain Alzheimers Drug Sales Price Trend (2012-2017)
Table Spain Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table Spain Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Alzheimers Drug Sales by Type (2015 and 2016)
Table Spain Alzheimers Drug Market Share by Type (2015 and 2016)
Table Spain Alzheimers Drug Sales by Application (2015 and 2016)
Table Spain Alzheimers Drug Market Share by Application (2015 and 2016)
Figure Benelux Alzheimers Drug Sales and Growth Rate (2012-2017)
Figure Benelux Alzheimers Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Alzheimers Drug Sales Price Trend (2012-2017)
Table Benelux Alzheimers Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Alzheimers Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Alzheimers Drug Sales by Type (2015 and 2016)
Table Benelux Alzheimers Drug Market Share by Type (2015 and 2016)
Table Benelux Alzheimers Drug Sales by Application (2015 and 2016)
Table Benelux Alzheimers Drug Market Share by Application (2015 and 2016)
Table Eisai Basic Information List
Table Eisai Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Alzheimers Drug Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Alzheimers Drug Sales Market Share (2012-2017)
Table Decartis Basic Information List
Table Decartis Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Decartis Alzheimers Drug Sales Market Share (2012-2017)
Table Shire Basic Information List
Table Shire Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Shire Alzheimers Drug Sales Market Share (2012-2017)
Table Janssen Basic Information List
Table Janssen Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Alzheimers Drug Sales Market Share (2012-2017)
Table Forest Laboratories Basic Information List
Table Forest Laboratories Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Forest Laboratories Alzheimers Drug Sales Market Share (2012-2017)
Table H. Lundbeck Basic Information List
Table H. Lundbeck Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure H. Lundbeck Alzheimers Drug Sales Market Share (2012-2017)
Table Merz Basic Information List
Table Merz Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merz Alzheimers Drug Sales Market Share (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Alzheimers Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daiichi Sankyo Alzheimers Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimers Drug
Figure Manufacturing Process Analysis of Alzheimers Drug
Figure Alzheimers Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimers Drug Major Manufacturers in 2015
Table Major Buyers of Alzheimers Drug
Table Distributors/Traders List
Figure Germany Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure Germany Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Figure France Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure France Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Figure UK Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure UK Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure Russia Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure Italy Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure Spain Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Alzheimers Drug Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Alzheimers Drug Revenue and Growth Rate Forecast (2017-2021)
Table Europe Alzheimers Drug Sales Forecast by Type (2017-2021)
Table Europe Alzheimers Drug Sales Forecast by Application (2017-2021)